VYX insider plans sale of 12,750 common shares

A person associated with VYX filed a Form 144 indicating a proposed sale of 12,750 shares of common stock through Fidelity Brokerage Services LLC on the NYSE.

Rhea-AI Filing Summary

A person associated with VYX filed a Form 144 indicating a proposed sale of 12,750 shares of common stock through Fidelity Brokerage Services LLC on the NYSE. The filing lists an aggregate market value of approximately $104,594.21 for these shares and includes a CUSIP-style identifier of 138069898.

The shares to be sold were acquired in several prior transactions: an open market purchase of 3,648 shares on 08/29/2024 for cash, and three restricted stock vesting events from the issuer providing 3,209 shares on 02/01/2025, 4,892 shares on 03/15/2025, and 1,001 shares on 02/01/2026 as compensation.

Key Figures

Shares proposed for sale: 12,750 shares Aggregate market value: $104,594.21 CUSIP-style identifier: 138069898 +4 more

7 metrics

Shares proposed for sale 12,750 shares Common stock to be sold through Fidelity Brokerage Services LLC

Aggregate market value $104,594.21 Value associated with 12,750 common shares proposed for sale

CUSIP-style identifier 138069898 Identifier listed for the common stock

Open market purchase shares 3,648 shares Acquired on 08/29/2024 for cash

Restricted stock vesting 02/01/2025 3,209 shares Common stock received as compensation

Restricted stock vesting 03/15/2025 4,892 shares Common stock received as compensation

Restricted stock vesting 02/01/2026 1,001 shares Common stock received as compensation

Key Terms

Form 144, restricted stock vesting, open market purchase

3 terms

Form 144 regulatory

"A person associated with VYX filed a Form 144 indicating a proposed sale"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock vesting financial

"three restricted stock vesting events from the issuer providing 3,209 shares"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

open market purchase financial

"an open market purchase of 3,648 shares on 08/29/2024 for cash"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does VYX’s latest Form 144 filing disclose?

The Form 144 for VYX discloses a proposed sale of 12,750 shares of common stock with an aggregate market value of about $104,594.21, to be sold through Fidelity Brokerage Services LLC on the NYSE.

How many VYX shares are planned for sale under this Form 144?

The filing indicates a proposed sale of 12,750 shares of VYX common stock. These shares have an aggregate market value of approximately $104,594.21 according to the information in the Form 144.

What is the basis of acquisition for the VYX shares listed in the Form 144?

The VYX shares were acquired via a 3,648-share open market purchase on 08/29/2024 and three restricted stock vesting compensation events totaling 3,209, 4,892, and 1,001 shares on specified dates.

Which broker and exchange are involved in the proposed VYX share sale?

The proposed VYX share sale is to be executed through Fidelity Brokerage Services LLC, with the common stock indicated for trading on the NYSE, as specified in the Form 144 details.

What is the reported market value of the VYX shares in this Form 144?

The Form 144 reports an aggregate market value of approximately $104,594.21 for the 12,750 VYX common shares proposed for sale through Fidelity Brokerage Services LLC on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 02:39 PM Accepted by SEC EDGAR 08/13/2026 - 02:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002010339
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NCR Voyix Corp
SEC File Number	001-00395
Address of Issuer	864 SPRING ST NW ATLANTA GEORGIA 30308
Phone	9178219817
Name of Person for Whose Account the Securities are To Be Sold	Tadele Beimnet
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	12750	104594.21	138069898	08/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/29/2024	Open Market Purchase	Issuer			3648	08/29/2024	Cash
Common	02/01/2025	Restricted Stock Vesting	Issuer			3209	02/01/2025	Compensation
Common	03/15/2025	Restricted Stock Vesting	Issuer			4892	03/15/2025	Compensation
Common	02/01/2026	Restricted Stock Vesting	Issuer			1001	02/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Beimnet Tadele
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)